Genomics

Dataset Information

0

R-Roscovitine improves motoneuron function in mouse models for Spinal Muscular Atrophy.


ABSTRACT: Neurotransmission defects and motoneuron degeneration are hallmarks of Spinal Muscular Atrophy, a monogenetic disease caused by the deficiency of the SMN protein. In the present study, we show that systemic application of R-Roscovitine - a Cav2.1 / Cav2.2 channel modifier and a Cyclin-dependent kinase 5 (Cdk-5) inhibitor - significantly improved survival of SMA mice. In addition, R-Roscovitine increased Cav2.1 channel density and sizes of the motor endplates. In vitro, R-Roscovitine restored axon lengths and growth cone sizes of Smn-deficient motoneurons corresponding to enhanced spontaneous Ca2+ influx and elevated Cav2.2 channel cluster formations independent of its capability to inhibit Cdk-5. Acute application of R-Roscovitine at the neuromuscular junction significantly increased evoked neurotransmitter release, the frequency of spontaneous miniature potentials, and lowered the activation threshold of silent terminals. These data indicate that R-Roscovitine improves Ca2+ signaling and Ca2+ homeostasis in Smn-deficient motoneurons which is generally crucial for motoneuron differentiation, maturation, and function.

ORGANISM(S): Mus musculus

PROVIDER: GSE112771 | GEO | 2020/01/28

REPOSITORIES: GEO

Similar Datasets

2023-01-05 | GSE197638 | GEO
2005-10-30 | E-MEXP-453 | biostudies-arrayexpress
2014-09-09 | PXD000666 | Pride
2020-02-08 | MSV000084939 | MassIVE
2015-12-18 | E-GEOD-75600 | biostudies-arrayexpress
2015-12-18 | GSE75600 | GEO
2015-12-18 | GSE75599 | GEO
2015-12-18 | E-GEOD-75599 | biostudies-arrayexpress
2014-12-01 | GSE59506 | GEO
2023-02-08 | GSE222976 | GEO